Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma

INTRODUCTION: Syndecan-1 (SDC1) has multiple functions in tumorigenesis in general and specifically in pancreatic cancer. We aimed to evaluate SDC1 as a diagnostic and prognostic biomarker in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: In this case-control study, patients newly d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yablecovitch, Doron, Ben-Horin, Shomron, Picard, Orit, Yavzori, Miri, Fudim, Ella, Nadler, Moshe, Levy, Idan, Sakhnini, Emad, Lang, Alon, Engel, Tal, Lahav, Maor, Saker, Talia, Neuman, Sandra, Selinger, Limor, Dvir, Revital, Raitses-Gurevich, Maria, Golan, Talia, Laish, Ido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132524/
https://www.ncbi.nlm.nih.gov/pubmed/35297817
http://dx.doi.org/10.14309/ctg.0000000000000473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132524/
https://www.ncbi.nlm.nih.gov/pubmed/35297817
http://dx.doi.org/10.14309/ctg.0000000000000473

Ejemplares similares